A vaccine that primes the immune system to attack prostate cancer can extend the lives of men in the advanced stages of the disease, researchers say. Men who had the experimental vaccine lived on average 8 to 9 months longer than men who had inactive, placebo injections.What do we know already?About 35,000 men are diagnosed [...]
Only one in 100 women with symptoms typical of ovarian cancer, such as persistent bloating or pelvic pain, actually has the disease, researchers reported on Thursday.
…
NEW YORK (Reuters Health) – Having type 2 diabetes in the family more than doubles a woman’s own risk of developing the disease, new research shows.
NEW YORK (Reuters Health) – Only one in 100 women with symptoms typical of ovarian cancer, such as persistent bloating or pelvic pain, actually has the disease, researchers reported on Thursday.
(NaturalNews) As NaturalNews has previously reported, omega-3s, the fatty acids found primarily in cold water fish like salmon, have a host of health benefits, including alleviating depression (http://www.naturalnews.com/027285_omega-3_depression_fatty…
Image Caption: According to a NIST study, vaccines that have not been removed from their packaging (most often a cardboard box), retain their temperature longer than those that have been unpacked and placed in trays. Moreover, the standard-sized refrig…
Health agencies say drinking raw milk is inherently risky but proponents say it’s a magic elixir that boosts immune resistance and cures disease. Who’s right? A look at the science behind raw milk.
NEW YORK, Jan. 26 /PRNewswire-FirstCall/ — Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (NYSE Amex: MGT), and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software which assists radiologis…
Researchers trying to restore vision damaged by disease have found promise in a tiny implant that sows seeds of new cells in the eye.The diseases macular degeneration and retinitis pigmentosa lay waste to photoreceptors, the cells in the retina that tu…
Federal health officials on Monday approved Danish drugmaker Novo Nordisk’s once-daily injection for treating type 2 diabetes but said more safety studies are needed before it can be cleared as a first-line treatment for the disease.